Article
Effect of enzyme therapy and prognostic factors in 69 adults with Pompe disease: an open-label single-center study
26 Sept 2012
Abstract excerpt
BACKGROUND: Enzyme replacement therapy (ERT) in adults with Pompe disease, a progressive neuromuscular disorder, is of promising but variable efficacy. We investigated whether it alters the course of disease, and also identified potential prognostic factors. METHODS: Patients in this open-label single-center study were treated biweekly with 20 mg/kg alglucosidase alfa. Muscle strength, muscle function, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
